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Abstract
Helminth infections are highly endemic in parts of the world where the two killer
epidemics caused by Mycobacterium tuberculosis (M.tb) and the human immunodefi-
ciency virus (HIV) intersect. Sub-Saharan Africa is hardest hit by this epidemiological
overlap. Consequently, several studies have investigated the immunological outcomes
of helminth coinfection with either HIV or M.tb, to elucidate the central hypothesis
that chronic infection with helminths exacerbates the course of HIV and tuberculosis
disease.  However,  there  is  no  conclusive  evidence  to  confirm  whether  helminth-
induced  immunity  modulates  HIV-  and  TB-specific  immune  responses  and  their
pathogenesis or vice versa. The present chapter summarizes the epidemiology, clinical
course,  and  immune  interactions  during  helminths  and  HIV/TB  coinfections  and
undertakes a systematic review of the existing literature published from Africa on
this subject. The aim was to determine if chronic helminthiasis has a negative impact
on HIV and TB infections. A PubMed search was undertaken with no language and
time  restrictions.  Search  terms  used  included  a  varied  combination  of  “Helminth
coinfection and immunity and TB coinfection or TB immunity and HIV coinfection
or HIV immunity and Africa.” Names of individual species were also permutated in
the search terms.  Reviews and bibliographies of  selected articles were screened to
identify additional relevant articles or studies. Of the total 1021 articles retrieved, 47
were  relevant  with  31  helminth  and  HIV  coinfection  and  16  helminths  and  TB
coinfection articles. While many studies failed to find a negative impact of helminth
infection  on  immune  responses  to  HIV  and/or  TB,  a  significant  number  found
evidence  of  deleterious  effects  of  coinfection  with  helminths  such  as  immune
activation, impaired Th1 responses to TB antigens,  higher viral  loads,  lower CD4+
counts, and increased risks of antiretroviral immunologic failure, mother to child HIV
transmission or TB disease. Some of the helminth-induced immune dysregulation was
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reversed  by  deworming,  while  some  studies  found  no  benefit  of  antihelminthic
treatment.  More studies particularly in Southern Africa are needed to increase the
much sought evidence of the impact of deworming among HIV‐infected individuals
as this seems the most feasible,  cost‐effective intervention with little or no serious
adverse  effects.  Lastly,  with  the  expansion  of  ART  and  increased  access  to  HIV
treatment,  the  effects  of  helminths  on  vaccines,  TB,  and  antiretroviral  treatments
efficacy also need serious consideration, in light of the suggestive evidence of possible
immunologic failure due to helminth coinfection.
Keywords: helminths, Mycobacterium tuberculosis, human immunodeficiency virus, co‐
infection, immune‐response, Africa
1. Introduction
1.1. Overview
Helminthiasis  is  an  infection  with  either  flukes  (trematodes),  tapeworms  (cestodes),  or
roundworms (nematodes) [1]. These worms are highly endemic in parts of the world where
the two killer epidemics caused by Mycobacterium tuberculosis (M.tb) and the human immu‐
nodeficiency  virus  (HIV)  intersect  [2].  This  epidemiological  overlap  between  helminthic
infections, TB and HIV, is more common in lower and middle‐income countries, particularly
sub‐Saharan Africa (SSA). This is one of the hardest hit regions with regards to HIV and
tuberculosis [2], while helminth infections are also highly endemic in this part of the world
[3]. Almost 70% of the population infected with HIV resides in SSA, which also carries two‐
thirds of the global burden of helminthiasis [2, 3]. Regrettably, helminth infections as part of
the neglected tropical diseases (NTDs) are still largely neglected and not a prioritized research
domain in most regions where they are highly prevalent and overlap with HIV and M.tb.
This raises important research questions about the public health implications of helminth
coinfection with HIV and/or M.tb in terms of pathogenesis and treatment outcomes of all
these diseases. Furthermore, although individual helminth‐, HIV‐, and M.tb‐specific immune
responses have been extensively investigated [2], the precise immune correlates of protection
remain mostly unknown.
Several studies have investigated the immunological aspects of helminth coinfection with
either HIV or M.tb, to elucidate the central hypothesis that chronic infection with helminths
exacerbates the course of HIV and tuberculosis disease [2]. Owing to the complexity of the
interaction at molecular, cellular, and humoral levels, the differences in study designs resulting
from financial and ethical challenges of properly designed randomized control trials for such
studies, many of these investigations have reported inconclusive or contradictory results. As
a result, to date, there is no conclusive evidence to confirm whether helminth‐induced
immunity modulates HIV‐ and TB‐specific immune responses and their pathogenesis or vice
versa.
There is a need therefore to constantly explore the work on the immunological consequences
of dual infections in order to condense and update this knowledge for policy makers in terms
Human Helminthiasis66
of a holistic management of coinfections in areas where all these infections are coendemic. The
present chapter aims to review published research on the immune interactions during
coinfection with helminths, HIV, and M.tb in the African region, a continent with a very high
burden of all three infectious diseases. A brief description of the epidemiology, clinical course,
and immune interactions during helminths and HIV/TB coinfections is given and then
followed by a systematic review of the existing literature on this subject.
1.2. Epidemiology of helminthiasis
More than 2 billion people worldwide are infected with helminths including geohelminths or
soil-transmitted helminths, schistosomes, and filarial worms, the vast majority of whom are in
low-/medium-income countries. Individuals who are affected frequently harbor more than
one species of worm at a time [4]. The major human helminth species of public health impor-
tance include Ascaris, Trichuris, Hookworms (Necator americanus, Ancylostoma duodenale),
Trichinella, Filaria, Onchocercaria, Ecchinococcus, Enterobius, Strongyloides, Taenia, and Schistosoma
species. It has been estimated that schistosomiasis and soil-transmitted helminths (sTH)
together account for 40% of all the tropical disease burden excluding malaria and that
infectious and parasitic diseases are the primary causes of death worldwide [5, 6].
Soil-transmitted helminths alone constitute the highest burden. Globally, an estimated 438.9
million people (95% confidence interval (CI), 406.3–480.2 million) were reported to be infected
with hookworm in 2010, 819.0 million (95% CI, 771.7–891.6 million) with A. lumbricoides, and
464.6 million (95% CI, 429.6–508.0 million) with T. trichiura [6]. In underdeveloped regions,
geohelminths cycle via pollution of the soil by feces containing worm ova or eggs from infested
humans. Individuals get infected through ingesting eggs in undercooked, unwashed, and
unpeeled fruits and vegetables, in contaminated water sources, or eggs ingested by children
who play in the contaminated soil and then put their hands in their mouths without washing
them. In hookworm infections, eggs hatch in the soil, releasing larvae which penetrate the skin
of people walking barefoot on the contaminated soil. In the case of schistosomes, water is
polluted by urine and/or feces [4]. These epidemiological cycles have been exacerbated because
of overcrowding in densely populated informal settlements without adequate sanitation or
clean water, owing to rapid urbanization and migration. Transmission is therefore directly
linked to availability of clean water supplies, poor hygiene, inadequate sanitation, the presence
of infective worm eggs in the environment, and climatic factors. In other developing countries
such as Central America and the Caribbean and parts of East and Southeast Asia, socioeco-
nomic and sanitation improvements and rollout of large-scale regular deworming programs
have reduced the previously high infection rates. In Central and Southern Asia, large numbers
of helminth infections still occur in certain regions owing to variations in environmental and
socioeconomic conditions, while in South America helminthiasis is distributed in pockets of
poverty-stricken indigenous populations. In the Middle East, transmission is limited by hot
and dry weather but high prevalence is still found in areas with suitable climate within
informal settlements [3]. In developed countries, the general availability of efficacious de-
worming drugs, clean water, and effective sanitation has eliminated most of these parasites
Helminthiasis: A Systematic Review of the Immune Interactions Present in Individuals...
http://dx.doi.org/10.5772/106429
67
such that more serious infections do not occur in these regions and mostly minor or imported
cases are reported [7].
In general, helminths develop through three stages: eggs, larva, and adult worms, which
determine both their epidemiology and pathogenesis in humans [8]. An example is illustrated
in the case of soil‐transmitted helminths where the eggs have a 3‐week maturation stage in the
soil that requires temperate, moist, and humid soil before they become infective [4]. Subse‐
quently, these worms are most prevalent in regions with tropical and subtropical climate. In
terms of the pathogenesis, larvae and eventually adult worms may cause direct pathology
through migration, metabolic activity, or blockage and damage to the internal organs they
finally parasitize.
1.3. Epidemiology of HIV
Globally, 36.7 million [34.0–39.8 million] people were living with HIV at the end of 2015 [9].
During the 35 years of the epidemic, more than 70 million people have been infected with HIV
globally and about 35 million people have died [10]. The distribution of the HIV infection varies
dramatically from region to region. Globally, sub‐Saharan Africa is the most severely affected,
with nearly 70% of the people living with HIV worldwide being from the region. At least one
in every 25 adults (4.4%) in this region is living with HIV [10]. The data as at the end of 2014
is summarized in Table 1 and illustrates the skewed distribution of the HIV virus across the
globe [11]. The sub‐Saharan region has consistently been carrying the heaviest burden of the
HIV infection globally.
Region Number of people living with HIV in 2014
Sub‐Saharan Africa 25.8 million
Asia and the Pacific 5 million
Western and Central Europe and North America 2.4 million
Latin America 1.7 million
Eastern Europe and Central Asia 1.5 million
Middle East and North Africa 280,000
The Caribbean 240,000
Adapted from UNAIDS data http://www.avert.org/global‐hiv‐and‐aids‐statistics [11].
Table 1. Global distribution of HIV infection (2014).
1.4. Epidemiology of Mycobacterium tuberculosis
Tuberculosis (TB) remains a major global public health problem and ranks second only to HIV
as a cause of death worldwide [12]. TB is an infectious disease caused by the bacillus Myco‐
bacterium tuberculosis (M.tb). It typically affects the lungs (pulmonary TB) but can disseminate
to affect other sites as well (extra pulmonary TB). The disease is spread in the air when people
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who have pulmonary TB disease expel bacteria, for example, by coughing. It is estimated that
a third of the world’s population is infected with M.tb. In 2015, the World Health Organization
reported 9 million TB cases with 1.5 million deaths annually [13]. Furthermore, according to
the WHO, the African region has more than 24% of the world’s TB cases and deaths, while
approximately 78% of total TB deaths and 73% of TB deaths among HIV-negative people
occurred in the African and the Southeast Asian regions combined [13]. On a global scale, the
African region alone accounts for at least 80% of TB cases dually infected with HIV worldwide.
This is because in many African countries, the tuberculosis and HIV epidemics are fueling each
other.
In general, a relatively small proportion of the estimated 2–3 billion people infected with M.tb
globally will develop TB disease during their lifetime (approximately 10%) [14]. This is because
although healthy people often will get infected by the bacilli, they are usually able to fight it
off or keep it under control to a large extent. Other people may only succumb to TB disease
years later, often when the immune system has been weakened by conditions such as HIV
infection, resulting in the reactivation of latent subclinical M.tb infection. Thus, it has been
established that the two categories of people developing TB disease include (i) those who have
been infected with TB bacilli and (ii) persons with compromised immune systems, possibly
due to other health conditions. Among the latter, HIV, diabetes, silicosis, low body weight, and
certain medical treatments, among others, have been established as known risk factors for the
development of TB disease.
Important factors in the management of TB include early detection, treatment, and manage-
ment of infected individuals in order to curb unabated transmission of this air-borne infection.
Detection and treatment relies heavily on the diagnostic capacity and linkage to care. To date,
the most widely used method for diagnosing TB worldwide remains sputum smear micro-
scopy, in which bacteria are observed in sputum samples examined under a microscope, a
method which was developed over 100 years ago. However, in countries with more developed
laboratory capacity, the cases of TB are also diagnosed via the culture method which is
currently the gold standard in TB diagnostics. Technological advancements in the last few years
have resulted in the use of rapid molecular tests to diagnose TB. Use of these techniques, such
as the GeneXpert, is now on the increase, with some countries now gradually phasing out the
use of smear microscopy for TB diagnosis [15].
TB is a poverty-related disease. As such, the financial demands of proper diagnosis using
laboratory techniques are juxtaposed by the limited resources in poor regions, and the financial
deprivation among the poor hinder optimum access to health care facilities. These factors
imply that a significant proportion of TB patients remains either unrecognized and untreated
or not notified, thus exacerbating transmission. Without treatment, the natural cycle of TB
infection is that a person deteriorates progressively, with the term “consumption” having been
used in the old days to describe the disease. The death rate in untreated TB cases is very high.
Studies from the prechemotherapy era showed that at least 70% of people who had microbio-
logically confirmed TB died within 10 years of the infection. Currently, the effective chemo-
therapeutic management of normal drug-sensitive TB lasts for at least 6–9 months. This long
treatment duration, coupled with side effects of anti-TB drugs, leads to noncompliance
Helminthiasis: A Systematic Review of the Immune Interactions Present in Individuals...
http://dx.doi.org/10.5772/106429
69
resulting in the emergence of drug-resistant TB in recent years [15]. The treatment of drug-
resistant TB is much more complicated requiring much longer treatment regimens of up to 2
years, an even so, with very poor prognosis and suboptimum treatment outcomes. Treatment
outcomes therefore also bear a direct impact on the epidemiology of tuberculosis.
1.5. Clinical course and immune responses during helminthiasis and HIV coinfection
Helminthiasis can be due to infection with a wide range of species which occupy a variety of
niches within the human body ranging from intestinal lumen, lymphatics, intravascular, or
intracellular compartments [1]. The clinical course will then differ from one species to another
depending on the course of infection and maturation cycle in the host and where the adult
worms eventually reside. The current work will not attempt to dissect the clinical course of
each species. Broadly, the clinical course of helminthiasis is associated with their infection route
and the final tissue or organ in which the adult worms reside and multiply.
Helminths have complex life cycles within the human host and undergo a series of develop-
mental stages in different parts of the human body. These different stages result in the host
being exposed to various stage-specific antigens in a range of host tissues and organs such as
the skin, lungs, gut, heart, liver, bladder, and brain and pass through the circulatory and
lymphatic systems [1]. Subsequently, the clinical manifestations can be associated with the
early infection phases such as during the larval entry and migration such as the hookworm’s
ground itch skin, the perianal itch, and pruritis vulvae in enterobiasis [1]. Migrating larvae
may also induce immune reactions as they pass through the tissues, such as the cutaneous
syndrome as a result of hookworm penetrating the skin. Another is illustrated by the devel-
opment of Ascaris lumbricoides after the ingested eggs have hatched in the human gastrointes-
tinal tract [1, 8]. The larvae migrate through the blood and via the lungs where they cause an
eosinophilic pneumonitis syndrome, before being coughed up and reswallowed into the
intestinal tract where they establish as adult worms [1]. The worms may cause pathology
directly as they migrate through organs causing tissue damage, or indirectly through the
immune response they induce. A case in point is the schistosomiasis-induced inflammatory
response and the pathological sequelae associated with the eggs lodged in the urogenital
mucosa and organs [16].
The parasites have different lifespans, which vary from species to species, for example, adult
schistosome worms can live for up to 5 years in the host in the absence of chemotherapy.
Onchocecaria volvulus has a life expectancy of up to 8–10 years while Ascaris lumbricoides is 1
year. Those with a short life cycle have a faster reinfection rate after chemotherapy and are
highly fecund, for example, an adult Ascaris female can produce 200,000 eggs per day [17].
Helminthiasis is also associated with a wide variety of clinical symptoms ranging from
gastrointestinal (diarrhoea, vomiting, pharyngeal irritation, cough, dyspnea, hoarseness
nausea, bloating, malabsorption), systemic (anemia, lymphedema, cystercercosis epileptic fits)
to organ occlusion. Some infections are cleared by the host’s immune response while most
establish and become chronic. It is noted that clinically, many infected individuals experience
minor symptoms or remain asymptomatic. Eighty percent of the heavy infections are carried
by 20% of the infected population and these individuals suffer serious life-threatening disease
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[17]. However, owing to the large number of infected individuals globally, this small percent-
age translates to large numbers of people with such morbidity. Importantly, the full-scale
implications of helminthiasis even in the absence of symptoms and overt disease is the result
of their subtle but deleterious impact on the other major killer pathogens such as the HIV and
M.tb as outlined in the following sections.
1.5.1. Immune response to helminths
Although helminths comprise of a spectrum of species, a striking phenomenon found during
helminthiasis is an almost universal immune response elicited by these pathogens. The
response is characterized by the following archetypical features:
• Consistent induction of a strong T helper 2 (Th2) immune response by CD4+ T helper 2 cells
with the production of type 2 cytokines: interleukin (IL)-4, IL-5, IL-9, IL-10, and IL-13.
• Increased levels of regulatory cells, molecules, and cytokines.
• Classic eosinophilia, increased numbers of mast cells, and basophils accompanied by very
high immunoglobulin E (IgE) levels.
• Existence in the host for protracted periods, sometimes years, in the presence of strong
immune responses directed against the parasites.
• The resultant chronic activation of the immune system from the persistent worm and egg
or larval antigenic challenge is associated with an increased rate of programmed cell death
(apoptosis).
• Induction of specific and generalized immune suppression (anergy) as one of the strategies
to survive in the face of strong immune responses [2].
Early in the infection, macrophages and dendritic cells are the first line of defense in the innate
immune response. These cells interact with parasite antigens and present them to T cells and
also secrete type 1 and inflammatory cytokines such as interleukin (IL)-12, tumor necrosis
factor alpha (TNFα), IL-6, and IL-8 [17, 18]. Other cell types such as the NK T cells in the gut
mucosa secrete IL-4, promoting the differentiation of the CD4 T cells toward a Th2 phenotype
[18]. These Th2 cells will secrete Th2 cytokines and also promote antibody isotype switch to
IgE [18]. CD4 T cells therefore play a key role in the development of the strong Th2 adaptive
immune response to helminths. Cytokines also recruit and prompt proliferation of other
granulocytic cells such as eosinophils, mast cells, and basophils which mediate extracellular
killing and expulsion of the worms through increased mucus secretion by goblet cells [18, 19].
A variety of mechanisms through which helminths evade the strong immune responses have
been elucidated. Central among these is the increased number of regulatory cells which play
a key role in dampening the immune response [2, 19]. These cells secrete the downregulatory
cytokines IL-10 and transforming growth factor β (TGFβ) which in turn increases cytotoxic T
lymphocyte antigen-4 (CTLA-4) expression in T cells. On the other hand, the costimulatory
molecule CD28 which facilitates T-cell intracellular signaling and activation in response to
antigenic stimulation is decreased during helminth infection [2]. This costimulatory molecule
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is essential for completion of T-cell activation after the T-cell receptor binds the antigen
presented in association with the major histocompatibility complex (MHC) [18]. CTLA-4
competes with CD28 for binding in T cells, as a regulatory mechanism to prevent uncontrolled
immune responses. Cells continually stimulated by parasite antigens in the absence of CD28
fail to mount an effective immune response and remain anergic [2, 18]. Increased CTLA-4
induced by chronic helminthiasis will outcompete the CD28 binding, thereby rendering the T
cells partially activated and unresponsive [2].
Other mechanisms of immune diversion by helminths include secretion of decoy molecules
and cytokine homologs such as the macrophage-inhibitory factor (MIF) which switches
macrophages to differentiate toward a type 2 phenotype that is counter inflammatory.
Helminths also secrete protease inhibitors that interfere with antigen presentation and cell
proliferation [19]. These pathogens also modulate innate cells such as the dendritic cells and
macrophages toward the Th2 phenotype inducing alternatively activated macrophages. The
diversion and regulation of the immune response toward a favorable niche such as promoting
wound healing; dampening of the inflammatory type 1 toward Th2; induction of alternatively
activated macrophages that do not secrete IL-12 (which promotes the differentiation of Th1
cells); and secretion of other molecules that interact with the host tissues are all mechanisms
that optimize the existence and survival of the parasites in vivo without causing extensive harm
and possible death of the host [19, 20].
Other key cellular changes that occur during helminthiasis include decreased numbers of
CD4+ and increased frequency of CD8+ cells [21], increased expression of chemokine receptors
CCR5 and CXCR4 in T cells [22], and in vaginal mucosal cells [16]. Another worm-induced
immunomodulatory mechanism is the selective upregulation of programed death 1 ligand,
which subsequently binds to program death-1 in T cells, thus rendering them anergic and
prone to increased apoptosis [2, 19].
1.5.2. Clinical course and immune response to HIV
The immune response to HIV differs among infected individuals. The course of the infection
is determined by several factors such as the viral fitness or virulence, the host genetic factors
such as the association of the HLA-B27, HLA-B*5701, HLA-B*5703, HLA-B*5801, and HLA-
B57 alleles [23, 24], and CCR-5 mutation [25] with resistance, as well as the immune response
particularly the cytokine microenvironment—with the predominance of type-1 cytokines
being more favorable. The cells of the innate immune system, the NK cells, are the source of
antiviral interferons secreted in the primary phase before induction of the adaptive immune
responses [18]. The effective control of HIV is chiefly dependent on the development of potent
HIV-specific cytotoxic T lymphocyte response (CTL) mediated by the Th1 CD8+ lymphocytes.
This was aptly demonstrated in both animal models and human studies early in the advent of
HIV [26–28]. The simultaneous appearance of the CTL at the point of peak viremia is followed
by the decrease in viral replication and establishment of the viral set point during the early
phase of the HIV infection and the association between higher numbers of CTL, viral sup-
pression and slower decline of CD4+ cells during all phases of the HIV infection [29].
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The development and maintenance of competent CTLs is also dependent on robust HIV‐1
specific CD4+ responses (particularly HIV‐1 gag‐specific). Paradoxically, the classic immuno‐
logical characteristic of HIV disease progression is the extensive attrition of the CD4+ lym‐
phocytes, attributed to the fact that during the HIV infection not only HIV‐infected cells are
affected, but uninfected bystander CD4+ cells are also depleted [30]. The overall depletion of
the CD4+ cells is mediated via several mechanisms, including direct cytopathic effects on
infected cells, indirect bystander killing, and increased activation‐induced programed cell
death or apoptosis [2].
Other prominent cellular changes during HIV infection include increased numbers of CD8+
cells, which remain high throughout the infection phases. The main functions of these cells
include the secretion of the antiviral Th1 cytokine, interferon gamma (IFNγ), as well as
cytolytic destruction of viral‐infected cells through the granzymes and perforin system [18].
The innate cells also secrete TNFα, IL‐6, and IL‐8. However, it has been shown that the
consistently high numbers of CD8+ cells are not related to increased antiviral potency [29] and
that their function wanes as the infection progresses, although the numbers remain high.
Regulatory cells also increase because of the chronic antigenic challenge and immune activa‐
tion. These changes are also accompanied by increased expression on T cells, of downregula‐
tory molecules such as the cytotoxic T lymphocyte antigen 4 (CTLA‐4), and the negative
regulator of T‐cell activation molecule, program death 1 (PD‐1), as well as decreased costimu‐
latory molecules, particularly CD28, which plays a key role in the induction of T lymphocyte
response to antigen [18]. Normally, the CTLA‐4 competition with CD28 for binding down
modulates the immune stimulation to prevent a pathologic runaway or uncontrolled immune
response. During chronic HIV infection, this homeostasis is disturbed by higher‐than‐normal
levels of CTLA‐4 secreted by the upregulated regulatory T cells (Tregs) which also secrete high
levels of IL‐10 and transforming growth factor β (TGF β) [2]. The increased levels of IL‐10 and
TGF β are responsible for the generalized immune suppression with disease progression.
Decrease in type 1 cytokines (IL‐2), a lymphoproliferative cytokine and the antiviral interferon
gamma (IFNγ) and ascendancy of Th2 cytokines have been associated with HIV disease
progression. The total effect is inability of T cells to respond to cognate and unrelated antigens
and increased programmed cell death (apoptosis) [2]. The early viremic phase of the HIV
infection is also characterized by marked increases of mainly inflammatory cytokines such as
IFNγ, IFNα, IL‐15, IL‐22 TNFα, CXCL10, and regulatory IL‐10, known as the cytokine storm.
These are secreted by infected CD4+CCR5+ T cells, activated dendritic cells, monocytes,
macrophages, NK cells, NKT cells, and HIV‐specific T cells [29].
Owing to the chronic nature of the HIV, chronic immune activation and increased levels of
regulatory cells is also another striking feature of the infection. The immune activation
correlates with CD4 decline and increased apoptosis [30]. HIV infection is known to stimulate
B cell and antibody forming cells. In the past, owing to the rapid mutation of the virus, the
protective effects of antibodies remained contentious. However, with the advancement of
molecular and computational research tools, there has been recent interest in exploiting the
neutralising antibodies for therapeutic vaccine development with promising results [31].
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1.5.3. Immune interaction during helminth and HIV coinfection
It is recognized that during coinfection, the effects of immune modulation and regulation is
bi-directional, in other words, immune response to HIV can modulate the response to hel-
minths [32] and vice versa. However, the focus of this work is on helminthiasis, and therefore
we will examine the influence of helminths on HIV and M.tb. Several immune mechanisms
suggest that immune responses to helminths are deleterious to immune control of intracellular
pathogens such as HIV. The interaction in a dually infected host may either increase suscept-
ibility or enhance cell-cell infection and virus replication thereby indirectly increasing
transmission. The key mechanisms that are proposed to drive this interaction are summarized
below.
1.5.3.1. Increased viral replication and transmission
The classic induction of a strong Th2 immune response by helminths downregulates the critical
Th1 CTL response required for the control of HIV. In addition, HIV has been shown to replicate
more readily in Th2 cells [33]. Uncontrolled viral replication increases transmission to other
hosts (high viral load) and within the same individual. Helminthiasis and HIV infection are
chronic infections, with chronic immune activation being the classic feature in both infections
[2]. It is known that the HIV virus hijacks the host’s natural transcription process for its own
replication. The transcription factor NF-Kβ, which is present in all activated cells, binds to both
host DNA promoter and viral long terminal repeat sequences (LTR) which then initiates viral
transcription [18]. In addition, the nuclear factor of activated T cells (NF-AT) stabilizes the
postfusion HIV complex and facilitates reverse transcription of the virus [34]. Proinflammatory
cytokine signaling pathways, particularly TNFα, IL-1, and IL-2, induce these transcriptional
factors [18]. IL-6 also synergizes with TNFα in monocytes to enhance HIV replication [34].
Increased levels of proinflammatory cytokines such as TNFα and IL-2 are well documented in
chronic helminthiasis [2, 35]. In that way, availability of increased numbers infected, activated
CD4+ T cells enhances viral replication.
One of the classic features of helminthiasis is increased production of immunoglobulin E (IgE).
This antibody isotype has been shown to increase viral replication as shown by increased
production of the HIV capsid protein 24 (p24) and viral mRNA in a culture system. The
crosslinking of the cell surface molecule CD23 by IgE leads to the production of cyclic
adenosine monophosphate (cAMP), nitric oxide (NO), and tumor necrosis factor-α (TNFα),
which enhance viral replication and thereby accelerate progression to AIDS [36].
1.5.3.2. Increased susceptibility to HIV
Upregulation of chemokine receptor molecules (CCR5 and CXCR4) [16, 22] by helminths
increases receptor molecules on CD4-positive cells, thereby increasing the numbers of HIV
susceptible cells, enhancing cell-cell infection and replication of the virus. Eosinophils
constitute one of the key cellular responses during helminthiasis. Activated eosinophils
express CD4 molecules, and have been shown to be infectable with HIV in vitro [37, 38]. Their
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increased numbers in genital and rectal mucosa may facilitate increased virus transmission
during hetero- and homosexual interaction, respectively.
Similar to HIV, helminth infections have been reported to result in the depletion of CD4+ cells
[21]. This suggests that helminth-infected individuals may be more susceptible to HIV infection
as the CD4+ cells are critical for both provision of help for CD8+ cell (CTL) development, type
1 cytokine secretion as well and mounting an effective immune response to antigenic chal-
lenge [18]. In addition, CD4+ cell depletion has been directly linked to immune activation [30]
which is present in chronic helminthiasis.
Both helminth and HIV infections are accompanied by increased regulatory cell networks. This
results in a high degree of reduced capacity to respond to cognate and bystander (unrelated)
antigen stimulation. The chronic immune activation is also associated with increased apoptosis
and rapid cell turnover which results in clonal exhaustion and diminished numbers of immune
cells [2]. Immune activation by both helminths and HIV result in both accelerated CD4+ cells
depletion and HIV replication. In that way, infected, activated CD4+ T cells can therefore be
prone to depletion by the viral infection/replication cycle and thus increases susceptibility to
HIV and other infections.
1.5.3.3. Uncontrolled HIV infection
The increased regulatory cells dampen immune responses not only to parasite-specific
antigens but also to bystander antigens, as well as the ability of helminth infections to diverge
immune responses [19] result in a high degree of reduced capacity to respond to antigen and
immune stimulation. The chronic immune activation is associated with increased apoptosis
and cell turnover results in clonal exhaustion and diminished numbers of immune cells,
generally reducing the ability of the immune cells to control infectious pathogens including
HIV.
One of the consequences of the induction of alternatively activated macrophages by helminths
is the conversion of arginine to ornithine. Arginine is required for the production of nitrogen
and oxygen intermediate radicals for intracellular killing [19]. Reduction of the innate intra-
cellular killing capability of the immune system promotes uncontrolled intracellular virus
propagation.
1.6. Clinical course of M.tb infection during helminthiasis and Mycobacterium tuberculosis
coinfection
1.6.1. Clinical course of M.tb infection
While most individuals who acquire TB infection are able to contain the infection as latent TB
infection (LTBI), in a small subset of individuals (5–10%), LTBI may progress to active TB
disease, a situation that may be prompted by many factors, among them a weakened immune
system. LTBI is often detected by the extent of the immune response to M.tb antigens such as
purified protein derivative (PPD) or tuberculin skin test (TST). This often measures the release
of IFN-γ a hallmark cytokine which is central in the TB immune response [39, 40]. Individuals
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with LTBI have no clinical or radiological evidence of disease and may live for years without
realizing it.
The host mechanisms by which some individuals remain protected while others later develop
TB disease remains incompletely understood [41]. However, among the various factors genetic
factors of both the host and the pathogen may play an important role in the progression of
latent infection to active disease. Other factors such as immune status and the general health
condition of the host may also play an important part in this reactivation of latent TB infection.
There is now an increasing body of knowledge in the understanding of LTBI being a spectrum
of both immunological and microbiological changes rather than binary classification of latent
infection and active TB disease [42].
1.6.2. Immune responses to M.tb infection
In pulmonary tuberculosis, generally, the immune response is characterized by the involve-
ment of many different cell types with a predominance of CD4+ T cells [43]. Once the bacilli
reach the lower respiratory tract, alveolar macrophages and lung epithelial cells are the first
cells that encounter M.tb during primary infection. The defense mechanisms by the macro-
phages include growth inhibition, innate killing mechanism, phagosome-lysosome fusion,
generation of reactive oxygen intermediates, and generation of reactive nitrogen intermedi-
ates, particularly nitric oxide as well as participation in the adaptive immune response through
antigen presentation to T cells [39]. The macrophages also acquire the ability to stimulate type
1 CD4+ Th1 cells or secrete proinflammatory cytokines.
The induction of these inflammatory responses initiates the development of a granuloma
[39, 40], where different T-cell populations participate in protective immune responses. Also
of note is the effector function of CD4+ Th1 cells which is mainly mediated by the production
of cytokines, such as IL-12, TNF-α, and IFN-γ [44, 45]. IFN-γ, which is secreted by activated
T cells is an important mediator of the immune response to M.tb, as it upregulates antimy-
cobacterial processes and antigen presentation by macrophages [39, 43]. The cytokine IFN-
γ and natural killer (NK) cells act as the principal activating factors in the control of
mycobacterial infection. The induction of IFN-γ is regulated by IL-12. That the Th1 immune
response is critical is highlighted by the increased susceptibility to TB disease in patients
treated by TNF-α suppressing drugs such as steroids [41]. The induction of significant Th1
(IL-12, IFN-γ, and TNF-α) and Th17 responses (IL-17 and IL-23) is thus central to the control
of tuberculosis [46]. In recent years, the realization that Th17 cells also play a critical role in
host’s control of TB has come under the spotlight. Studies from animal models have shown
that the secretion of IL-17 homologs coupled by IL-22 helps to establish an optimal Th1
response [47].
In sub-Saharan Africa, the immunology of TB is further complicated by the widespread
association of TB with HIV, the protracted period of chemotherapy which inadvertently may
result in poor treatment compliance and, consequently, the emergence of drug-resistant and
multidrug-resistant M.tb strains [14]. While there is a licensed vaccine against tuberculosis
(BCG) [44, 48], the efficacy of protection it offers against pulmonary tuberculosis is variable
and has been shown to wane over time, possibly due to immune alteration by prevalent chronic
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infections and consequent impairment of immune response to recall antigens [45]. Further‐
more, the lack of a point of care diagnostic tool means that TB diagnosis [15] and, consequently,
treatment and interruption of transmission does not happen as promptly as required in order
to bring the global TB epidemic under control [49].
1.6.3. Mechanisms of interactions between helminths and M.tb
The fact that both M.tb and helminth infection are widely distributed geographically, on a
global scale, allows for considerable overlap of the infections. By nature helminth infections
are chronic and their persistent presence can lead to considerable morbidity [46]. The presence
of chronic helminth infection has been known to induce a wide range of immunomodulation
mechanisms mainly dominated by a Th2 type immune response and the subsequent release
of Th2‐related cytokines, such as IL‐4, IL‐5, and IL‐13. On the other hand, the immune
responses induced by helminth infection tend to be antagonistic to those induced by M.tb
infection [45, 50]. While helminth and M.tb infection mechanisms are vastly different with M.tb
being a single‐celled organism and helminths being multicellular, several authors have
demonstrated the negative association between helminth and mycobacterial infections [51].
The predominant Th2 biased response in helminths has been demonstrated to downregulate
the Th1 response that is characteristic and constitutes an essential defense for control of M.tb.
It has been hypothesized that by creating an antiinflammatory environment, helminths
exacerbate M.tb infection by antagonizing the protective inflammatory responses needed for
the tuberculosis infection.
In addition, helminths can modulate the host’s adaptive immune responses by inducing T‐
regulatory (Treg) cells or secreting antiinflammatory and regulatory cytokines [19, 52]. Such
effects could induce a significant inhibitory effect on protective M.tb‐induced immune
responses and/or control of mycobacterial infection. Studies examining association between
helminth infection immune response indicators and TB infection have illustrated that worms
may impair immunity against mycobacterial infections. Other literature also shows that
helminth‐infected individuals exhibit markedly lower Th1 type responses and IFN‐γ produc‐
tion to M.tb antigens relative to dewormed controls [53].
Other studies have further dissected the immune mechanisms triggered by each pathogen in
isolation and also investigated their interaction. In this regard, it has been demonstrated that
coincident infections with helminths can modulate the strong M.tb‐specific Th1 immune
responses by driving Th2 and/or Treg cells [54]. Furthermore, enhanced Treg function
associated with helminth infections have been found to potentially suppress Th1 responses
[55] suggesting that intestinal helminth coinfection is associated with a reduced Th1 type
immune response in active TB cases while both Th1 and Th17 responses have been shown to
be diminished in latent tuberculosis [56].
Many soil‐transmitted helminths larvae migrate through the lungs where they can potentially
cause an eosinophilic pneumonitis [1]. Eosinophils are induced by a Th2response and may
have a deleterious, direct impact on coexisting M.tb lung infection which requires a Th1
response. In addition, individuals coinfected with helminths and M.tb were also shown to have
more advanced disease shown by the number of diseased zones [56]. It is not known whether
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the helminths could have exacerbated the lung pathology directly or indirectly through an
inflammatory process.
Another deleterious interaction between helminths and M.tb is the induction of alternatively
activated macrophages by helminths [19]. The resultant attenuation of nitric oxide production
by these cells inhibits one of the key intracellular killing mechanisms against M.tb which can
exacerbate the intracellular survival and multiplication of the bacilli. IL-4 stimulates the
production of IgE antibodies, classically induced by helminths. High IgE levels have been
shown to be inversely associated with a positive tuberculin skin test in Ascaris-infected
individuals [57] suggestive of an impaired M.tb response associated with helminthiasis.
While a number of studies point to negative impact of helminth infection to the immune
responses to mycobacterial infection, other clinical studies also appear to show that helminth
infections have little effect on the pathogenesis or pathology of active TB [50]. However, it is
important to note that most of these findings are from observational studies with very few
longitudinal studies having been performed to examine these hypotheses. In the absence of
such long-term longitudinal studies and clinical trials, it remains important to synthesize the
current knowledge and present a summary of the findings to date in order to inform policy
and further research efforts.
Table 2 summarizes the main mechanisms through which helminth infections are proposed
to modulate the HIV and mycobacterium tuberculosis immune responses and course of the
diseases.
Effects of helminth infection  Impact on HIV [1]   Impact on Tuberculosis [1, 13]
Cellular alterations
• Lower CD4 and higher
CD8
• Alternatively
activated macrophages
• Classic Eosinophilia
• CD4 T helper cell critical for HIV
control: Uncontrolled HIV replication.
• Impaired IL-12 production:
impaired NK cell intracellular
killing of HIV.
• Activated eosinophils express CD4
and are infectable by HIV: Increased
HIV replication; promotes hetero-and
homo-sexual transmission in genital
and rectal mucosa.
• CD4 T-cell help essential for protective
interferon gamma production: Enhanced
TB infection.
• Compromised lung anti-tuberculosis
defenses.
• Reduced NO and RO intracellular killing
• Eosinophilia associated with a Th2
response which dampens Th1 anti-
tuberculosis responses
Predominant type 2
response Hyper IgE
immunoglobulinaemia
• Decreased type 1 CTL
responses essential for HIV control:
• Uncontrolled HIV replication
• Increased HIV replication and
apoptosis
• Reduced Th1 immunity to mycobacteria.
Th1 cytokines ( TNFα, IL-6 and IL-8)
essential for granuloma formation)
• Inhibited TLR-mediated protective
immunity to TB
• Impaired BCG vaccine efficacy.
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Effects of helminth infection  Impact on HIV [1]   Impact on Tuberculosis [1, 13]
• High IgE associated with high TB
incidence
Chronic immune activation • Increased receptor molecules
(CD4, CCR5, CXCR4), enhanced HIV
entry to cells, cell-cell transmission;
Increased transcription factors and virus
replication; increased virus
transmission in the population.
• Inability to cope with TB, enhanced
active pulmonary TB
Regulatory cytokines;
specific and generalized
immune suppression
• Attenuated immunity
increases susceptibility to HIV and
faster progression to AIDS.
• Impaired protective TB immunity,
• Reactivation of latent TB.
Increased apoptosis • Increased CD4 T-cell loss,
Uncontrolled virus replication
• CD4 T-cell help required for granuloma
formation: Inability to contain TB;
disseminated infection.
Table 2. Summary key immune interactions between helminthiasis, HIV, and M.tb infections.
2. Systematic review of immune interactions during helminth and HIV or
Mycobacterium tuberculosis coinfection
2.1. Methodology
2.1.1. Search strategy
The electronic database PubMed was searched for relevant articles with no language and time
restrictions. Search terms used included a varied combination of “Helminth coinfection and
immunity and TB coinfection or TB immunity and HIV coinfection or HIV immunity and
Africa.” Names of individual species were also permutated in the search terms. Reviews and
bibliographies of selected articles were screened to identify additional relevant articles or
studies.
2.1.2. Study selection
All retrieved articles were sequentially searched for relevance by title, abstract, and full text.
Two authors independently searched through the titles and abstracts to identify potentially
relevant papers for inclusion, and consensus on potential eligibility reached with differences
resolved through discussion. Full text articles of potentially relevant articles were screened for
relevance (Figure 1). Articles were excluded from the review if they were (1) not from Africa,
(2) based on experimental animal models, (3) review articles, and (4) epidemiological surveys
of coinfections without any immunological outcome assessment being reported. The majority
of other potentially relevant articles were from countries from Southeast Asia especially India
and were therefore excluded.
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Figure 1. Flow chart showing study selection.
2.1.3. Inclusion criteria for immune interaction
Included were those studies that investigated immune interactions that will worsen HIV
disease progression defined by lowered CD4 counts, immunologic failure, increased viral load,
impaired immune response, altered immune response-impaired Th1 responses (low IFNg,
IL-12); alternatively activated Mǿ; highly activated immune system; altered distribution of
immune cells; altered cytokine profile (Th2 biased; increased Tregs); and anergy (decreased
capacity to respond to antigens). For TB, immune interactions were defined by outcomes that
result in impaired granuloma formation; impaired Th1 responses (low IFNg, TNFa, IL-12);
alternatively activated Mǿ; altered cytokine profile (Th2 biased; increased Tregs); and anergy
(decreased capacity to respond to antigens).
2.1.4. Data extraction
A structured data extraction form was used with the following information being extracted:
author(s), year of publication, country, subregion, study design, type of coinfection, study
population, and main immunological outcome. Diagnosed and/or reported helminth species
were also recorded where available.
3. Results
Literature search in the electronic bibliographic database resulted in 953 unique references and
68 more were extracted from the additional manual searches (Figure 1). Of these, 73 articles
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were considered relevant and assessed for eligibility. A total of 47 relevant articles were
identified through PubMed search and cross-referencing of selected articles. Of these 12 were
from Southern Africa, 32 from East Africa, and three from West Africa.
A total of 31 relevant studies were on helminth coinfection with HIV, and 18 were from East
Africa (seven Ethiopian, five Kenyan, three Ugandan, and four Tanzanian), 10 from Southern
Africa (four South African, two Zimbabwean, two Malawian, and one Zambian), and two from
West Africa (both from Uganda). In addition, 16 relevant studies were on helminth coinfection
with TB, and 13 were from East Africa (nine Ethiopian, three Ugandan, and one Kenyan), two
from Southern Africa (all South African), and one from West Africa (Cameroon).
3.1. Helminth and HIV coinfection immunological outcomes
Of the 31 helminth and HIV coinfection studies, 22 (71%) reported some negative effect of
helminthiasis on HIV parameters (Table 3). Fifteen studies investigated the effects of treat-
ing helminth infection on HIV viral load, CD4 count, immune activation, or disease progres-
sion. Eight of the 15 (53%) reported a positive impact of treating worm infection by either
stabilizing or decreasing viral load [59, 62, 65, 73] or increasing or stabilizing CD4+ counts
[16, 62, 65, 68, 82] or decreasing IgE levels [85] and seven reported no impact of deworming
[16, 34, 63, 64, 72, 77, 80], two of which reported no benefit of empiric deworming of HIV-
and helminth-coinfected individuals [73, 79]. Two studies reported high immune activation
associated with coinfection [71, 80] which was not affected by anthelminthic treatment [80].
Five studies reported increased HIV coreceptor molecules CCR5, CXCR4 [16, 22, 60, 71, 81],
or CD4 molecules [70], among helminth-infected individuals. One study reported increased
odds of antiretroviral treatment immunological failure induced by helminthiasis [74], while
another reported increased expression of inflammatory markers [66] and another showed
increased HIV susceptibility of peripheral blood monocytes obtained from helminth-infect-
ed individuals [58]. An increased risk of mother-to-child transmission by helminth-infected
mothers was reported in one study [61]. One study reported decreased capacity to prolifer-
ate in response to antigen stimulation and reduced type I cytokines among HIV-/helminth-
infected individuals [78].
Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
Shapira-Nahor
et al. [58]
1998 Ethiopia East Africa PBMCs of helminth-
infected, immune-
activated
individuals    
Increased HIV
susceptibility of
PBMCs from
helminth-infected
individuals.
Lawn et al. [34] 2000 Kenya East Africa Prospective
cohort
30 Schistosomiasis HIV-
infected
persons    
No correlation
between eradication
of Schistosoma
infection and
reduction in HIV
load. Instead, a
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Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
transient
posttreatment
interval-dependent
increase in viral load
was found.
Wolday et al.
[59] 
2002 Ethiopia East Africa Prospective
cohort
56 Helminth-infected
and noninfected in
asymptomatic
HIV-1-infected
individuals    
At baseline heavier
egg load was
associated with
higher virus load. At
6 months’ follow-up,
there was a mean
decrease of −0.36
log10 in HIV load
among 13
successfully treated
participants.
Elliot et al. [60] 2003 Uganda East Africa Prospective 68 Helminth-infected
and uninfected HIV-1
positive, ART-naive
individuals    
There was increased
expression of HIV
coreceptor molecules
CCR5 and CXCR4 on
cells of Schistosoma-
infected adults.
Secor et al. [22] 2003 Kenya East Africa Prospective Schistosoma-infected
HIV-1-positive and
negative
individuals    
Increased expression
of HIV coreceptor
molecules CCR5 and
CXCR4 on cells of
Schistosoma-infected
adults.
Gallagher
et al. [61]
2005 Kenya East Africa Retrospective
cohort
 936 Helminth and/or
malaria-infected HIV-
positive and HIV-
negative pregnant
women    
Helminth-infected
mothers had in
increased risk for
MTCT of HIV
compared to
uninfected mothers,
which correlated
with cord blood
lymphocytes
production of
interleukin-5/
interleukin-13 in
response to helminth
antigens.
Kallestrup et al.
[62]
2005 Zimbabwe Southern
Africa
Prospective
cohort
287 Schistosomiasis in
individuals with or
without HIV-1
infection    
Early treatment of
schistosomiasis was
associated with a
significant increase in
CD4 counts, and
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Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
arrested increase in
viral load, while
there was an increase
in HIV RNA load in
the delayed-
treatment group.
Modjarrad et al.
[63]
2005 Zambia Southern
Africa
Prospective 428 Helminth-infected
and uninfected HIV-1
asymptomatic
individuals    
No significant
association between
treatment of
helminths and
reduction of viral
load was found
Hosseinipour
et al. [64]
2007 Malawi Southern
Africa
Prospective 389 Helminths in HIV-
uninfected and
HIV-infected
individuals    
Neither helminth
parasitic infection
nor treatment thereof
had an impact on
HIV viral load.
Nielsen et al.  
[65]
2007 Tanzania East Africa RCT 27 Filarial parasite-
infected and
uninfected HIV-
infected
individuals    
A significant
decrease in HIV load
(54%) and an
insignificant increase
in CD4% were
observed in the HIV-
positive individuals
with filarial co-
infection at 12 weeks
after treatment.
Zinyama-
Gutsire  et al.
[66]
2009 Zimbabwe Southern
Africa
Prospective
cohort
379 Schistosomiasis
infection and HIV-1
co-infection    
S. haematobium- and
S. mansoni-infected
participants had
significantly higher
MBL levels than
uninfected
partcipants. All
MBL2 variants were
not associated with
HIV-1 infection but
promoter variants LY
and LL were
significantly
associated with S.
haematobium
infection.
Babatunde et al.
[67]
2010 Nigeria Western
Africa
Cross-
sectional
135 Intestinal parasites in
HIV patients    
Patients with CD4+
count <200/μl had
more coccidian
parasites in their
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Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
stool and also had
higher prevalence of
intestinal
polyparasitism
ranging from 2 to 4
different species per
stool sample.
Walson et al.
[68] 
2010 Kenya East Africa RTC 1551 Helminth co-infection
in HIV-1-infected
adults    
Treatment of A.
lumbricoides with
albendazole in
HIV-1coinfected
adults resulted in
significantly
increased CD4 cell
counts during 3-
month follow-up.
Akinbo et al.
[69] 
2011 Nigeria West Africa Serial
sampling
method
2000 Intestinal parasites in
HIV-infected
patients    
Anaemia was
associated with CD4
count while
Cryptosporidium
species, Ascaris
lumbricoides,
hookworm, and
Taenia species were
the intestinal
parasitic agents
associated with
anemia.
Jourdan et al.
[70] 
2011 Malawi Southern
Africa
89 Women with S.
haematobium    
S. haematobium may
significantly increase
the density of HIV
target cells (CD4+ T
lymphocytes and
macrophages) in the
female genitals,
creating a beneficial
setting for HIV
transmission
Mkhize-
Kwitshana et al.
[71] 
2011 South Africa Southern
Africa
Cross-
sectional
62 Helminth and HIV
singly infected, dual-
infected and
uninfected
individuals    
People with both
helminth egg
excretion and high
Ascaris-IgE levels
had dysregulated
immune cells,
eosinophilia, higher
viral loads with more
immune activation
(HLADR, CCR-5 and
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Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
CD38 upregulated).
A modified Th2
helminth response in
individuals with egg
positive stools and
low Ascaris IgE
showed a better HIV
related immune
profile.
Idindili [72]  2012 Tanzania Eastern
Africa
Longitudinal
descriptive
 421 Parasitic infections in
HIV-infected
patients    
Patients coinfected
with helminths and
HIV had higher HIV
p24, and parasite-
infected patients had
lower CD4 cell
counts than parasite
free patients, but this
was not statistically
significant. Multiple
infection was
associated with CD4+
T cells <200/μl
compared to one
parasite coinfection.
Walson et al.
[73] 
2012 Kenya East Africa RCT  948 Helminth and
helminth-coinfected
adults    
There was no
evidence of the effect
of empiric
deworming in the
delaying of HIV
disease progression
in adults with HIV
Webb et al.
[74] 
2012 Uganda East Africa RCT  264 Helminths in HIV-
infected pregnant
women    
Hookworm and
Trichuris infections
were associated with
higher mean viral
load at enrolment,
and there p = 0.05
was some evidence
that albendazole
reduced viral load at
6 weeks
posttreatment (p =
0.05).
Efraim et al.
[75] 
2013 Tanzania East Africa Retrospective
cohort study
 351 Schistosome infection
in HIV-infected
patients’ responses on
ART    
Odds of developing
immunological
failure were four
times greater in
patients with
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Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
schistosome
coinfection.
Schistosome-infected
patients also had
significantly lower
CD4 count increases
on ART than
schistosome-
uninfected patients.
Mulu et al.
[76] 
2013 Ethiopia Eastern
Africa
220 Helminthic-infected
and uninfected HIV-1
patients    
Twelve weeks after
antihelminthic
treatment, helminth
infestations and their
treatment had no
significant effect on
CD4+ T-cell counts.
However, helminth-
infested individuals
had a higher level of
CD8 (+) T cells at
baseline, which was
significantly reduced
at 12 weeks after
antihelminthic
treatment.
Gebreegziabiher
et al. [77] 
2014 Ethopia East Africa Cross-
sectional
85 Helminth-HIV-co-
infected pregnant
women    
There was no
significant difference
in IL-4 response of
CBMCs between
helminth negative
and positive
participants.
Maternal helminth
infection had a
significant
association with the
IFN-γ response of
CBMCs, total IgE,
and cross-placental
transfer of TB-
specific IgG.
Mkhize-
Kwitshana et al.
[78] 
2014 South Africa Southern
Africa
Cross-
sectional
62 Helminth and HIV
singly infected, dually
infected and
uninfected
individuals    
Dual HIV/helminth
infection with egg
excretion and/or high
Ascaris IgE
phenotype may be
linked with poor
proliferative capacity
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Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
and deleterious
cytokine profile with
regards to HIV
control.
Lankowski
et al. [79] 
2014 Uganda East Africa Retrospective
observational
 5379 Helminth in HIV-
infected adults on
ART    
Empiric deworming
of HIV-infected
individuals on ART
conferred no
significant
generalized benefit
on subsequent CD4
count recovery. A
significant
association was
observed exclusively
in females and
during the initial
year on ART
Chachage et al.
[80] 
2014 Tanzania Eastern
Africa
Prospective
cohort
 386 Helminth coinfection
with HIV in
adults    
Trichuris, Ascaris,
and S. mansoni
infections correlate
with increased
expression of T-cell
activation markers
with relatively little
effect of helminth
treatment compared
to helminth-negative
controls. Contrary,
hookworm infection
was associated with
slightly decreased
frequency of HLA-
DR expressing.
Kleppa et al.
[16] 
2014 South Africa Southern
Africa
Prospective
cohort
 853 Female genital
schistosomiasis and
HIV target cell
density and
expression of the HIV
co-receptor
CCR5 in blood and
cervical cytobrush
samples    
Increased expression
of CD14+ monocytes
and CCR4+ CD4 cells
among
schstosomiasis-
infected (FGS
+)individuals (FGS+)
than from FGS-
women (4.7% vs.
1.5%, p = 0.018) in
blood and genital
samples which
decreased
significantly in both
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Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
compartments after
anti-schistosomal
treatment (p =  0.043).
Noormahomed
et al. [81] 
2014 MozambiqueSouthern
Africa
Cross-
sectional
601 Cysticercosis,
Schistosomiasis,
Toxocariasis, and
Echinococcosis
in HIV
patients    
Patients with CD4+
count between 200
and 500/μl had a
higher
seroprevalence to all
helminths than those
with less than 200/μl
cells and those with
more than 500 cells/
μl.
Abossie and
Petros [82] 
2015 Ethiopia East Africa 97 Helminth/HIV
coinfection    
CD4+ T-cell count in
the Ascaris
lumbricoides/HIV-
coinfected was
significantly higher
and after 15 weeks
and 6 months
postantihelminthics
treatment,
respectively. Also,
after antihelminthic
therapy, the CD4+ T-
cell count
significantly
increased in all
treated helminth
infections.
Kleppa et al.
[83] 
2015 South Africa Southern
Africa
Cross-
sectional
792 S. haematobium
infection and in HIV
infected    
Urogenital
schistosomiasis does
not influence the
number of circulating
CD4 cells.
Mengist et al.
[84]
2015 Ethiopia East Africa Cross-
sectional
550 Intestinal parasitosis
in HAART initiated
and HAART naive
pediatric HIV
patients    
Hook worm and
Taenia species were
IPs associated with
CD4+ T-cell counts
<350 cells/μl in
HAART naive
patients
Mulu et a [85]  2015 Ethiopia East Africa Prospective
cohort
130 Helminth-infected
and uninfected HIV-
infected
individuals    
Helminths showed a
high level of serum
IgE compared to HIV
patients without
helminths
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Authors Year Country Subregion Study
design 
Sample 
size 
Coinfections
and study
population     
Immunological
outcomes
coinfection. A
significant decline in
serum IgE level was
observed 12 weeks
after deworming and
ART of symptomatic
HIV‐infected patients
with and helminths
coinfection. There
was no significant
decrease in serum
IgE level among
asymptomatic HIV‐
infected individuals.
Table 3. Helminth HIV coinfection studies included in the systematic literature review.
As indicated in the summary results, the overall picture indicates that while some studies
reported no impact (on HIV infection) of deworming on helminth‐infected individuals, the
majority actually showed a beneficial effect. Other studies that analyzed different aspects such
as immune activation, proliferative capacity, inflammatory markers, and expression of
coreceptor molecules indicated a negative impact of helminth infection on HIV disease
markers. Indeed a sizeable proportion of these also failed to show any negative interaction
between helminths and HIV.
3.2. Helminth TB coinfection immunological outcome
The 16 helminth and TB coinfection studies investigated (1) the general immune responses
of helminthiasis with mycobacterial coinfections and (2) effect of intestinal helminths on the
immune response to naturally immunized or BCG‐vaccinated humans, and (3) effect of
antituberculosis chemotherapy on helminth‐infected TB patients with and without HIV
(Table 4). Generally, immune response studies of helminth‐ and mycobacterial‐coinfected
individuals revealed that co‐infection with helminths appear to dampen the proinflammatory
cytokine response while promoting a regulatory/Th2‐mediated immune response [90].
Studies that analyzed the interaction of helminth infection and response to M.tb antigen,
purified protein derivative (PPD), also showed a T‐cell‐mediated immune response skewed
toward a Th2 type response against helminth and PPD antigens. Similarly, BCG‐vaccinated
individuals infected with various helminths species also exhibited attenuated T‐cell and skin
responses with Malhotra et al. reporting a 26‐fold magnitude difference in IFN‐gamma
production in BCG‐vaccinated infants who were not exposed versus those who were
prenatally exposed to filariae and schistosomes [96, 93]. Thus, chronic worm infection was
noted to reduce the immunogenicity of BCG in humans [86]. In their study, Adams et al.
reported that TB patients were observed to have a higher total IgE and Ascaris‐specific IgE
(in comparison to controls), which declined significantly after treatment [87]. IgE levels were
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reported to be significantly higher in TB patients coinfected with HIV and helminths
compared to those without helminth coinfection with anti-TB chemotherapy significantly
reducing the serum IgE levels in HIV seronegative TB patients. Several other studies also
showed that the immune response in helminth-TB-coinfected individuals was characterized
by elevated IgE levels [87, 91]. Elliott et al. also reported a significant association between
eosinophilia, elevated IgE levels, and asymptomatic infection which improved with anti-TB
treatment [89]. Asymptomatic helminth infection was also observed to be associated with
increased regulatory T-cell and Th2 type immune responses by the same authors [92].
Authors Year Country Subregion  Study
design 
Sample
size 
Coinfections and
study population 
Immunological outcome 
Malhotra et al.
[86] 
1999 Kenya East Africa Cross-
sectional
33 Schistosoma
filariasis-infected
mothers and BCG-
vaccinated infants
and 2–10 year-olds
T-cell IFN-γ production
evaluated 10–14 months
after BCG vaccination was
26-fold higher for infants
who were not sensitized to
filariae or schistosomes in
utero relative to subjects
who experienced prenatal
sensitization.
Adams et al.
[87] 
1999 South
Africa
Southern
Africa
740 TB patients had higher
total IgE and Ascaris-
specific IgE than controls
before TB treatment and
declined after treatment.
Tuberculin induration
correlated inversely with
IgE in patients but not in
controls.
Stewart et al.
[88] 
1999 Cameroon West Africa 50 Helminth and
mycobacterial
infections in 5–16
year olds
There was a MF density-
related downregulation of
cellular responsiveness and
age-related skewing
toward type 2 which was
paralleled in response to
both the helminth antigen
and PPD.
Elias et al. [53] 2001 Ethiopia East Africa Prospective
cohort
240 Intestinal helminths
in naturally
immunized or BCG-
vaccinated College
students
BCG-vaccinated
individuals infected with
various helminths had
attenuated T-cell and skin
test responses.
Eliot et al. [89]  2003 Uganda East Africa Prospective
follow-up
625 Helminth and TB in
adult
High rates of subsequent
progression to active TB
were associated with
eosinophil counts ฀ 0.4 ×
109/L at enrolment.
(Eosinophilia associated
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Authors Year Country Subregion  Study
design 
Sample
size 
Coinfections and
study population 
Immunological outcome 
with schstosomiasis in this
study).
Kassu et al.
[90] 
2003 Ethiopia East Africa Long-term
cohort
64 Parasitic infection in
HIV-1-infected and
uninfected adult
Incidental intestinal
parasitic infections resulted
in a significant increase in
memory CD4+ T-cell
numbers both in HIV-
negative and HIV-positive
subjects. There was also a
significant increase in the
percentage of CD8+ HLA-
DR+ T cells (p < 0.05) in
HIV-positive subjects
coinfected with parasites.
Kassu et al.
[91] 
2004 Ethiopia East Africa Consecutive
sampling
241 Tuberculosis
patients with or
without intestinal
helminthic infection
and/or
HIV infection
IgE level was significantly
higher in patients
coinfected with intestinal
helminthes and HIV
compared to those infected
with helminthes or without
coinfection.
Antituberculosis
chemotherapy significantly
reduced serum IgE levels in
HIV seronegative
tuberculosis patients.
Elias et al. [92] 2006 Ethiopia East Africa Case
control
Cases
(n =
230)
Control
(n =
510) 
Helminth infections
in active
tuberculosis
patients
The odds of being a TB
patient increased with the
number of helminth species
per person: in individuals
with monoinfection it was
4.3 (95% CI 2.8–6.8); in
people infected with two
species was 4.7 (95% CI
2.5–8.7), and in patients
infected with three or more
helminths was 12.2 (3.9–
52.6).
Elias et al. [93] 2008 Ethiopia East Africa 280 Volunteers with
prior mycobacterial
infection and
asymptomatic
helminths infection
Chronic worm infection
reduces the
immunogenicity of BCG in
humans and this was
associated with increased
TGF-beta production but
not with enhanced Th2
immune response.
Webb et al.
[94] 
2011 Uganda East Africa RCT Women
(n =
Helminth- and HIV-
infected women and
Neither albendazole nor
praziquantel treatments
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Authors Year Country Subregion  Study
design 
Sample
size 
Coinfections and
study population 
Immunological outcome 
2356)
Infants
(n =
1115)
BCG-vaccinated
infants
affected infant response to
BCG, tetanus, or measles
immunization.
Abate et al.
[94] 
2012 Ethiopia East Africa Consecutive
sampling
295 Helminth=infected
TB patients with and
without HIV
Eosinophilia and elevated
IgE levels were
significantly associated
with asymptomatic
helminth infection. During
TB treatment, the worm
infection rate of HIV+/TB
patients declined from 31%
(10/32) at week 0 to 9%
(3/32) at week 2 of TB
treatment, whereas HIV
−/TB patients showed no
change from baseline to
week 2, 29% (13/45) vs.
22.2% (10/45).
van Soelen et al.
[57] 
2012 South
Africa
Southern
Africa
Cross-
sectional
271 A. lumbricoides and
M.tb in children
There was an inverse
association between
Ascaris IgE status and a
positive TST (OR = 0.6, p =
0.08), when adjusted for
age, and M.tb contact score.
The effect of being Ascaris
IgE positive significantly
reduced the odds of being
TST positive amongst
younger children while this
effect weakened with
increasing age.
Wassie et al.
[95] 
2013 Ethiopia East Africa Cross-
sectional
245 Healthy school
children aged from
12 to 20 years
A subset of children who
had a positive
QuantIFERON™ result but
a negative tuberculin skin
test.
Biraro et al.
[96] 
2014 Uganda East Africa Prospective
cohort
291? Helminth-coinfected
and newly infected
TB patients
Household contacts with
LTBI had elevated cytokine
responses to tuberculosis
antigens but coinfections
had little effect on cytokine
responses.
Gebreegziabihe
et al. [77] 
2014 Ethiopia East Africa Cross-
sectional
85 Helminth infections
in pregnant women
and immunity after
infection with TB
and neonatal
The IFN-γ response of
CBMCs to ESAT-6/CFP-10
cocktail was significantly
lower in helminth-positive
than helminth-negative
Human Helminthiasis92
Authors Year Country Subregion  Study
design 
Sample
size 
Coinfections and
study population 
Immunological outcome 
immune function
and immunity to TB
participants. Maternal
helminth infection had a
significant negative
association with the IFN-γ
response of CBMCs, total
IgE, and cross placental
transfer of TB specific IgG.
Abate et al.
[97] 
2015 Ethiopia East Africa Consecutive
sampling
121 Helminth-infected
TB patients
Asymptomatic helminth
infection is associated with
increased regulatory T-cell
and Th2- type responses
and a lower rate of sputum
smear positivity
Table 4. Helminth TB coinfection studies included in the systematic literature review.
A clinical trial by Webb et al. reported that neither treatment with albendazole nor praziquatel
affected infant BCG immune responses [94]. Another interesting finding was the increased
odds of being a TB patient for individuals who had more than one species of helminths reported
by Elias et al. [92]. In newly infected/latently infected TB household contacts, cytokine
responses to TB antigens were higher compared to coinfected individuals [96]. Furthermore,
several studies showed that chronic worm infection reduces the immunogenicity of BCG in
humans [96, 98]. Improved mycobacterial antigen-specific cellular responses in BCG-vacci-
nated persons were observed after treatment of helminthes.
4. Discussion
The extent of convergent distribution of tuberculosis, HIV, and helminth infection in sub-
Saharan Africa is evident in the selected literature in this review. Likewise, the contrasting
immune responses elicited by the extracellular helminthic parasites and intracellular HIV and
M.tb infections provide an immunobiologically plausible support for the antagonistic interac-
tion in coinfected hosts The review extracted 47 studies that investigated the immunological
interactions between helminthiasis and HIV and/or mycobacterium tuberculosis. The studies
were spread across the Western, Southern, and East Africa, the latter having the most relevant
articles (31 of 46) and the Western Africa the least (three articles). The scarcity of such studies
in West Africa may be due to that fact that this region, together with East Africa, has the lowest
HIV/AIDS burden compared to the worst affected Southern region. Interestingly though, the
East African region has a leading number of such investigations.
4.1. Immune response to helminths and HIV coinfection
Immunological consequences of coinfection with HIV and helminth infections were also
investigated. Different aspects of immunological outcomes were measured, and some studies
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did not find evidence of a negative interaction, others indicated a deleterious effect of helmin-
thiasis. The hallmark of helminth infections—(i) cellular changes, (ii) immune activation, (iii)
a Th2 biased immune profile, and (iv) increased regulatory cells associated with anergy were
addressed by the studies reviewed as well as other immune-related aspects of HIV such as
viral replication, increased susceptibility to HIV, and increased risk of transmission. Cellular
changes induced by helminthiasis include reduction of the central adaptive immune response
subset—the CD4+ cells. Helminth infections have been shown to be associated with decreased
frequencies of these cells [21].
It is generally accepted that a CD4 count less than 200 cells/μl predisposes HIV-infected persons
to opportunistic infections. Several investigations in this review demonstrated an association
between reduction of these cells and helminthiasis [67, 81, 84]. In their study, Akinbo et al. [69]
showed that a CD4 count of less than 200 cells/μl resulted in a significantly higher prevalence
of intestinal parasitic infections and Idindili et al. [72] reported that multiple infection was
associated with CD4+ T cells <200/μl compared to one parasite coinfection. In addition, the
prevalence of anemia in HIV-infected patients is high, while low CD4 count is a significant risk
factor of acquiring anemia. Some parasite species also induce anemia, such as the Trichuris
which burrow and suck blood from the small intestine of infected individuals. Akinbo et al.
[69] further demonstrated that A. lumbricoides, hookworm, and Taenia species in HIV-infected
individuals are parasitic agents associated with anemia. These human studies lend support to
the negative association between immune modulation by helminthiasis and HIV infection.
However, one study in this review failed to show this association, where urogenital schisto-
somiasis was not found to influence the number of circulating CD4+ cells [83].
Another change in the distribution of peripheral blood cells during helminthiasis is marked
increase in eosinophils, the key effector cells which play a specialized role in immunity to
helminths. These cells together with IgE are produced by CD4+ Th2 cells, indicating a pre-
dominance of these cells during helminthiasis. In the current review, the significant decline of
serum IgE level 12 weeks after deworming of both symptomatic and asymptomatic patients
[85] confirms the Th2 immune response induced by helminths [66]. As indicated earlier,
increased numbers of activated eosinophils that express CD4 molecules provide an extra
supply of HIV target cells at convenient sites for HIV infection during sexual encounter in
homosexual (rectal) or heterosexual (genital) mucosa of helminth-infected sexual partners.
Furthermore, the helminth-induced Th2 polarized immune response spills over to bystander
cells, influences the response to other nonparasite antigens, and skews them toward a Th2
phenotype [19]. In humans, ascariasis was associated with impaired Th1 responses to vibrio
cholera [99], which was later improved by deworming—treatment of Ascaris lumbricoides
resulted in enhanced antivibrio antibody production [100]. Likewise, significantly impaired
proliferative, T helper 1 (IL-2 and interferon γ) tetanus responses have been documented in
tetanus toxoid-vaccinated, onchocerciasis-infected children [101]. Gopinath et al. attributed all
these phenomena to a Th2-biased immune profile induced by helminths.
Thirty-two cases of new HIV cases were recorded in a 5-year cohort study involving 1055
individuals who were initially HIV negative, with a confirmed prior filarial infection [102].
This study demonstrated for the first time in humans, a significantly increased risk of HIV
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acquisition among lymphatic filariasis-infected individuals, lending strong support to the in
vitro study in this review that showed increased HIV susceptibility of PBMCs obtained from
filarial-infected individuals [58]. In another study, PBMCs from filarial-infected individuals
were also shown to be more susceptible to HIV infection [103]. In this study, viral replication
as measured by reverse transcriptase (RT) values were higher but not statistically significant
among the infected compared to the uninfected group and viral replication was significantly
reduced 1–2 years after treatment of filariasis. These in vitro findings, together with the four
studies extracted in the current review that reported increased expression of HIV coreceptors
among filarial- or schistosoma-infected individuals [16, 22, 60, 71], provide strong suggestive
evidence of increasing susceptibility to HIV by helminthiasis. These exemplify suggestive
evidence of a negative immune regulation consequence of helminthiasis on HIV control.
Chronic immune activation resulting from prolonged exposure to helminths is widely
described during helminthiasis [2, 19]. In this review two studies reported highly activated
immune profiles among HIV- and helminth-coinfected adults [71, 80]. Immune activation was
shown to correlate better with HIV disease progression and CD4+ cell decline [30]. Indeed,
treatment of parasitic infections showed a tendency to reduce the activation suggesting that,
together with other community-based intervention strategies, such treatment could be used
to downregulate immune activation and hence protect the host from being easily infected by
HIV. In a practical illustration of the deleterious effects of immune activation was the study by
Rizardi et al. [104] where simultaneous initiation of antiretroviral therapy (ART) and admin-
istration of cyclosporin-A (immunosuppressant) improved CD4 counts restitution in HIV-
infected individuals compared to their ART-only counterparts [105]. This finding strongly
demonstrated the negative relationship between immune activation and HIV pathogenesis,
and implications thereof for helminthiasis-induced chronic immune activation on HIV
aggravation.
In this review, helminths have been shown to modulate other aspects of the immune system
with potential negative consequences to other microbes. Mannose-binding lectin, part of the
innate mechanism required for nonspecific pathogen binding of foreign antigens, was
increased among schistosoma-infected individuals [66], which could impair this pathway of
immune response for other pathogens. In addition, other deleterious effects of helminthiasis,
such as increased risks of mother-to-child transmission of HIV [61] and immunological failure
on ART [75], as well as increased levels of HIV p24 (indicative of high virus load ) [73], were
reported in studies extracted in the review. Decreased proliferative capacity of lymphocytes
and reduced type 1 cytokines among HIV-helminth coinfected individuals [78] were also
reported.
One of the major attempts at addressing the possible deleterious effect of helminthiasis on HIV
infection is to determine whether deworming would reverse the immune dysregulation
induced by helminths among HIV-infected individuals. Like in many reported studies, the
results remain controversial. Of the 15 such studies, seven reported no impact of deworming
coinfected individuals, one even reported a transient increase in viral load after anthelminthic
treatment [34]. On the other hand, eight of the 15 studies reported a positive effect of deworm-
ing coinfected individuals, some reported an arrest or reduction of viral load after antihel-
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minthic treatment or an increase in CD4+ counts. Kleppa et al. [16] reported a significant
reduction of CD4+ CCR5 expressing T cells and monocytes in blood and vaginal samples after
antischistosomial treatment among young women. Mulu et al. [85], on the other hand, reported
a reduction of IgE levels among helminth-infected individuals after deworming, supporting
the concept that deworming positively impacts HIV/AIDS diseases progression.
In one study in Kenya, Walson et al. reported that albendazole-treatment of Ascaris lumbricoides
resulted in a significant increase in CD4+ counts in HIV-helminth-coinfected adults [68]. Two
years later the authors reported no benefit of empiric deworming of HIV coinfected individuals
in the same country [73]. Lawonski et al. [79] also reported no general benefit of deworming
helminth-HIV-coinfected individuals. Nonetheless, the latest Cochrane review (last updated
on the 29 September 2015) which included eight trials that enrolled 1612 participants concluded
that there is low quality evidence that treating helminth infections in HIV-infected adults may
have small short-term benefits on HIV disease progression and that deworming does not have
serious adverse effects [105]. It is important to note that conclusive results of empiric deworm-
ing of helminth- and HIV/M.tb-coinfected individuals are required. This approach would be
more cost-effective compared to targeted deworming of confirmed helminth-infected indi-
viduals. The diagnosis and confirmation of helminthiasis is expensive as it requires laboratory
equipment such as microscopes, culture systems for some species such as for the strongyloides
larva, ELISA readers and washers for serological confirmation in order to increase the low
sensitivity of microscopy, as well as a well-trained microscopist. Empiric deworming will
obviate the need for such expensive resources, particularly in poorly resourced settings where
these three infections frequently coexist.
4.2. Immune response to helminth and TB coinfection
Among 16 studies that analyzed immunological interactions between helminths and M.tb
coinfection there was evidence for a reduction in type 1 dependent cellular responses as shown
by decreased IFNγ production by T cells [77, 86] or low tuberculin skin test responses [57]. A
study by Guadalupe et al. [106] showed evidence of increased frequencies of IL-4 and IFNγ
CD4+ responses to Ascaris lumbricoides antigen stimulation in the cord blood of neonates born
of infected mothers. Frequencies of IFN-γ and IL-4 expressing CD4+ T cells in newborns born
of infected mothers were attenuated compared to those of noninfected mothers [106]. The
authors assert that the data provide evidence of in utero sensitization to Ascaris lumbricoides,
and raise the possibility that the immunological effects of infection start in the fetus. In an
earlier study, Malhotra et al. also reported related findings where they observed infants who
had experienced prenatal sensitization [86]. In such infants, the immune response to BGC
vaccination was shown to be biased against the Th1 response in those infants who were
exposed to filiarae or schistosomes compared to those who were not exposed and that this
immune status persists beyond infancy. These findings indicate a reduction of BCG immuno-
genicity or impaired TST responses by chronic helminth infection, which were further
corroborated by Gebreegziabiher et al. [77]. Thus, helminth infections have significant practical
implications and pose a significant threat to the effectiveness of the BCG vaccine, particularly
in areas with a high burden of helminth and TB infections.
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In another study, evidence of elevated Th2 responses, a classic feature of helminthiasis was
reported either through high total and Ascaris-specific IgE which declined after TB treatment
[87, 97] or IgE and eosinophilia, the latter associated with high rates of progression to active
TB disease [89]. In addition, helminth-induced upregulation of regulatory cells and Th2
responses were also associated with lower rate of sputum positivity [97]. These findings
indicate that helminths may have adverse consequences for TB disease and diagnostic efforts,
directly impacting on transmission control of TB disease. Yet another study reported increased
odds of having TB disease among helminth-infected individuals [92]. However, few studies
did not find such an interaction, for example, albendazole treatment did not have any effect
on BCG immune response in infants while Biraro and coworkers reported that helminth-latent
TB coinfection had no effect on cytokine responses to TB antigens [94, 96]. In one Ethiopian
study the immune responses to quantiferon and TST antigens in healthy children from an
endemic setting were found to be discordant [95].
In the main, these studies suggest a negative relationship between helminth infection and TB.
By and large, most of the studies showed that coinfection with helminth infection dampens
the immune response to both latent and active disease. This effect of a suppressed characteristic
antitubercular Th 1 immune response was observed regardless of age as the studies reported
corroborative findings for prenatally/in utero sensitized infants, young children, adolescents,
and adults alike. These findings have important implications in the prevention (vaccination)
and control of TB in helminth-TB endemic regions such as much of the developing world. With
helminthiasis being a silent disease and so very often asymptomatic, the results we present in
this study suggest that important policy and public health measures must be adopted in order
to bring under control or eliminate the two infections. An important intervention would be
comprehensive medical packages for suspected TB-helminth infections particularly in
endemic areas. In areas of the world with a high burden of HIV and TB, the WHO policy now
recommends screening for HIV for all TB patients and vice versa. In this same way our results
suggests that investigating for asymptomatic helminth infections in any suspected TB cases
may have important implications for the control of TB in coinfected individuals.
We however note that the results presented here were mainly derived from observational and
cross-sectional studies with very few clinical studies. Although a randomized clinical trial
could potentially be useful in providing more definitive evidence the ethical and cost impli-
cations of conducting such a study are difficult to justify. Prospective studies could also be
useful to determine whether the immune system rebounces after the treatment of both TB and
helminth infections. Although a few such studies were reported in the studies we examined,
the study design and research questions did not clearly address this question, hence the
findings were not very definitive.
5. Conclusion
The reviewed studies, like all others in this field have provided results in support and against
the hypothesis that chronic infection with helminths result in poor immunological and disease
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outcomes in coinfected hosts. However, there is evidence of immune alteration such as reduced
type 1 responses and increased Th2 and regulatory responses induced by helminth infection
in humans. Evidence for possible vaccine inefficiency, increased risks of mother-to-child
transmission, and unfavorable treatment outcomes shown in some of these studies confirm
the likelihood of a serious public health implication for both major infectious organisms,
HIV, and M.tb. In the face of the huge financial investments needed for vaccine development,
these efforts must be accompanied by insightful consideration of the fact that those vaccines
which ultimately reach the market will be rolled out in areas where there is a high likelihood
of widespread immune regulation. The fact that TB and helminths are diseases of poverty,
contrasts the large financial investment demand for vaccine and drug development with a
discouraging likelihood of a low return. Other mechanisms are therefore required to counter
widespread immune activation and regulation among the poor individuals exposed to
coinfections, as shown in this review. More studies particularly in Southern Africa are needed
to increase the much sought evidence of the impact of deworming among HIV-infected
individuals as this seems the most feasible, cost-effective intervention with little or no serious
adverse effects. Lastly, with expansion of ART and increased access to HIV treatment, the
effects of helminths on antiretroviral treatment efficacy also need serious consideration, in light
of the suggestive evidence of possible immunologic failure due to helminth coinfection.
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